DR. JOHN L LEDBETTER M.D. NPI 1225069065

NPI Details

DR. John L Ledbetter, M.D. is an interventional pain medicine pain medicine in Monroe, LA with 43 years of experience. The provider is interventional Pain Medicine is the discipline of medicine devoted to the diagnosis and treatment of pain and related disorders principally with the application of interventional techniques in managing subacute, chronic, persistent, and intractable pain, independently or in conjunction with other modalities of treatment. DR. John L Ledbetter, M.D. NPI is 1225069065. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL SCHOOL AT DALLAS
Graduation Year:1983

The provider's business location address is:

210 LAYTON AVE STE 20
MONROE, LA
ZIP 71201-548
Phone: (318) 323-6405
Fax: (318) 410-8290

The NPI 1225069065 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0480)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes (HCPCS:99152)
• Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint (HCPCS:64636)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint (HCPCS:64635)
• Injection of lower or sacral spine facet joint using imaging guidance, single level (HCPCS:64493)
• Injection of lower or sacral spine facet joint using imaging guidance, second level (HCPCS:64494)
• Injection of substance into lower spine canal using imaging guidance (HCPCS:62323)
• Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes (HCPCS:99153)
• Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level (HCPCS:64483)
• Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint (HCPCS:64634)
• Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level (HCPCS:64484)
• Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance (HCPCS:27096)
• Injection of substance into middle or upper spine canal using imaging guidance (HCPCS:62321)
• Injection of upper or middle spine facet joint using imaging guidance, single level (HCPCS:64490)
• Injection of upper or middle spine facet joint using imaging guidance, second level (HCPCS:64491)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint (HCPCS:64633)
• Smoking and tobacco use intensive counseling, 4-10 minutes (HCPCS:99406)
• Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
• Destruction of nerves supplying joint between spine and pelvis using imaging guidance (HCPCS:64625)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Injection of trigger points, 3 or more muscles (HCPCS:20553)
• Injection of trigger points, 1-2 muscles (HCPCS:20552)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)

The enumeration date for this NPI number is 7/6/2006 and was last updated on 1/26/2010.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.